In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.
作者信息
Henry D, Skidmore A G, Ngui-Yen J, Smith A, Smith J A
出版信息
Antimicrob Agents Chemother. 1985 Aug;28(2):259-64. doi: 10.1128/AAC.28.2.259.
Abstract
A total of 745 gram-negative and 313 gram-positive clinical isolates were tested against enoxacin, ticarcillin plus clavulanic acid, aztreonam, imipenem, and piperacillin and compared with commonly used antimicrobial agents. Ticarcillin plus clavulanic acid, imipenem, and piperacillin were active against Pseudomonas aeruginosa and Acinetobacter spp. and most Pseudomonas spp. Aztreonam was active against members of the family Enterobacteriaceae but was less effective against the nonfermenters. Enoxacin was active against the Enterobacteriaceae, P. aeruginosa, the staphylococci, and most Acinetobacter spp. but was less active against Pseudomonas spp. and streptococci. Imipenem was very active against all gram-positive and -negative organisms tested except for Pseudomonas maltophilia.
摘要
相似文献
1
In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.
Antimicrob Agents Chemother. 1985 Aug;28(2):259-64. doi: 10.1128/AAC.28.2.259.
2
3
Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
Antimicrob Agents Chemother. 1989 Aug;33(8):1268-74. doi: 10.1128/AAC.33.8.1268.
4
[Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):805-8.
5
Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
J Antimicrob Chemother. 1984 Feb;13(2):121-8. doi: 10.1093/jac/13.2.121.
6
In vitro antagonism between N-formimidoyl thienamycin and aztreonam, ticarcillin and ticarcillin/clavulanic acid.
Ann Microbiol (Paris). 1984 Jul-Aug;135B(1):111-5. doi: 10.1016/s0769-2609(84)80048-4.
7
8
Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
Diagn Microbiol Infect Dis. 1989 Mar-Apr;12(2):157-63. doi: 10.1016/0732-8893(89)90007-2.
9
Sensitivity pattern of gram negative bacilli to three beta-lactam/beta-lactamase inhibitor combinations using the automated API system.
Indian J Med Microbiol. 2007 Jul;25(3):203-8. doi: 10.4103/0255-0857.34759.
10
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
J Antimicrob Chemother. 1987 Jan;19(1):45-8. doi: 10.1093/jac/19.1.45.
引用本文的文献
1
Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.
Antimicrob Agents Chemother. 1993 Mar;37(3):474-82. doi: 10.1128/AAC.37.3.474.
2
In vitro susceptibility of Citrobacter species to various antimicrobial agents.
Antimicrob Agents Chemother. 1987 May;31(5):829-30. doi: 10.1128/AAC.31.5.829.
3
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
4
Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1986 Jul;30(1):35-8. doi: 10.1128/AAC.30.1.35.
5
Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1988 Jul;36(1):32-66. doi: 10.2165/00003495-198836010-00004.
6
Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.
J Clin Microbiol. 1989 Nov;27(11):2475-81. doi: 10.1128/jcm.27.11.2475-2481.1989.
7
[Susceptibility of clinically important Bacteroides species against enoxacin-metronidazole and enoxacin-clindamycin combinations].
Infection. 1989;17 Suppl 1:S11-3. doi: 10.1007/BF01643627.
8
Fluoroquinolone antimicrobial agents.
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
本文引用的文献
1
Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.
Antimicrob Agents Chemother. 1982 Jan;21(1):85-92. doi: 10.1128/AAC.21.1.85.
2
In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
Antimicrob Agents Chemother. 1980 Oct;18(4):557-61. doi: 10.1128/AAC.18.4.557.
3
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.
Antimicrob Agents Chemother. 1980 Jun;17(6):912-7. doi: 10.1128/AAC.17.6.912.
4
In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
Antimicrob Agents Chemother. 1984 Mar;25(3):392-4. doi: 10.1128/AAC.25.3.392.
5
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.
Antimicrob Agents Chemother. 1983 Oct;24(4):509-13. doi: 10.1128/AAC.24.4.509.
6
Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci.
Antimicrob Agents Chemother. 1983 Jul;24(1):61-9. doi: 10.1128/AAC.24.1.61.
7
Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
J Antimicrob Chemother. 1984 Feb;13(2):121-8. doi: 10.1093/jac/13.2.121.
8
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Antimicrob Agents Chemother. 1983 Nov;24(5):754-63. doi: 10.1128/AAC.24.5.754.
9
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
Antimicrob Agents Chemother. 1983 May;23(5):658-63. doi: 10.1128/AAC.23.5.658.
10
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
Antimicrob Agents Chemother. 1982 Apr;21(4):673-5. doi: 10.1128/AAC.21.4.673.
Zotero 插件